A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

Heck Matthias M.; Thalgott Mark; Schmid Sebastian C.; Oh William K.; Gong Yixuan; Wang Li; Zhu Jun; Seitz Anna-Katharina; Porst Desiree; Hoeppner Michael; Retz Margitta; Gschwend Juergen E.; Nawroth Roman

首页> 外文期刊>The Prostate >A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

【24h】

A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

机译：从全血中前列腺癌增强转录产物衍生的2基因检测组可预测生存率，并预测转移性去势抵抗性前列腺癌的治疗获益。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND. To determine a prognostic model derived from prostate cancer-enhanced transcripts in whole blood of castration-resistant prostate cancer (CRPC) patients and explore its applicability as a surrogate of treatment response.

机译：背景。为了确定源自去势抵抗性前列腺癌（CRPC）患者全血中前列腺癌增强转录本的预后模型，并探讨其作为治疗反应替代品的适用性。

著录项

来源
《The Prostate》 |2016年第13期|共9页
作者
Heck Matthias M.; Thalgott Mark; Schmid Sebastian C.; Oh William K.; Gong Yixuan; Wang Li; Zhu Jun; Seitz Anna-Katharina; Porst Desiree; Hoeppner Michael; Retz Margitta; Gschwend Juergen E.; Nawroth Roman;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类生物化学;
关键词
castration-resistant prostate cancer; KLK2; TMPRSS2; transcript; prognosis; whole blood;

机译：去势抵抗性前列腺癌;KLK2;TMPRSS2;转录本;预后;全血;

相似文献

外文文献
中文文献
专利

1. A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer [J] . Heck Matthias M., Thalgott Mark, Schmid Sebastian C., The Prostate . 2016,第13期

机译：从全血中前列腺癌增强转录产物衍生的2基因检测组可预测生存率，并预测转移性去势抵抗性前列腺癌的治疗获益。
2. Prognostic models for predicting overall survival in metastatic castration-resistant prostate cancer: a systematic review [J] . World journal of urology . 2020,第3期

机译：预测转移阉割前列腺癌整体存活的预后模型：系统评价
3. A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel [J] . Chi K. N., Kheoh T., Ryan C. J., Annals of oncology: official journal of the European Society for Medical Oncology . 2016,第3期

机译：预测多西他赛治疗后接受醋酸阿比特龙治疗的转移性去势抵抗性前列腺癌患者总生存的预后指标模型
4. Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer: A Decade of Progress and Ongoing Discoveries [C] . Leonel Hernez-Aya, Maha Hussain Genitourinary Cancers Symposium. . 2014

机译：转移激素敏感和阉割的前列腺癌：进步和持续发现的十年
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. The prognostic factors of effective ketoconazole treatment for metastatic castration-resistant prostate cancer: who can benefit from ketoconazole therapy? [O] . Guo-Wen Lin, Xu-Dong Yao, Ding-Wei Ye, 2012

机译：有效酮康唑治疗转移性去势抵抗性前列腺癌的预后因素：谁可以从酮康唑治疗中受益？
7. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer [O] . Johann S. de Bono, Howard I. Scher, R. Bruce Montgomery, 2008

机译：循环肿瘤细胞预测从转移性阉割抗癌前列腺癌治疗中的存活中受益

A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer

摘要

著录项

相似文献

相关主题

期刊订阅